Improving access to pre-exposure prophylaxis for HIV prescribing in a primary care setting
Authors:
Open Access
- 12 May 2022
- journal article
- research article
- Published by BMJ in BMJ Open Quality
- Vol. 11 (2) , e001749
Abstract
Although emtricitabine–tenofovir was approved for HIV pre-exposure prophylaxis (PrEP) in 2012, use by persons at risk of acquiring HIV has been limited. Because many primary care providers lacked familiarity and comfort prescribing PrEP, at our institution PrEP prescribing was concentrated among the infectious disease specialists, effectively limiting access. This project sought to increase the number of patients receiving new prescriptions for PrEP. The interventions targeted primary care providers (including internal medicine and family medicine), and were designed to increase the number of unique providers offering PrEP to their patients. The overall strategy was to expand the clinical scope of practice for primary care providers through education and provision of detailed care templates in the electronic health record. These initiatives were implemented through a series of informal Plan–Do–Study–Act cycles, then generalised throughout the medical system. To evaluate the success of the project, we queried the electronic medical record for all new prescriptions for PrEP, with provider name and specialty, for all outpatients 18 years of age and older from 2012 through 2020. In 2015, prior to the intervention, only 78 patients received new prescriptions for PrEP at our institution, and only 38% (30 of 78) of these were from primary care clinicians. After the intervention, the number of patients receiving PrEP increased to 190 in 2019, with 85% (162 of 190) prescribed by primary care providers. In addition, the number of primary care providers making a new prescription for PrEP increased from 20 in 2015 to 73 in 2019. We conclude that targeted clinical education, combined with electronic health record templates, was associated with a significant increase in PrEP prescribing.Keywords
This publication has 13 references indexed in Scilit:
- National trends in HIV pre‐exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017Journal of the International AIDS Society, 2020
- Estimation of new HIV diagnosis rates among high‐risk, PrEP‐eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United StatesJournal of the International AIDS Society, 2019
- Transgender women on oral HIV pre‐exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender menJournal of the International AIDS Society, 2019
- New USPSTF Guidelines for HIV Screening and Preexposure Prophylaxis (PrEP)JAMA Network Open, 2019
- Age-Associated Trends in Diagnosis and Prevalence of Infection with HIV Among Men Who Have Sex with Men — United States, 2008–2016MMWR. Morbidity and Mortality Weekly Report, 2018
- Improving the Documentation Process for Referrals into Diabetes Education: A Quality Improvement ProjectJournal of Community Health Nursing, 2018
- PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV SpecialistsAIDS and Behavior, 2016
- Prevalence of Diagnosed and Undiagnosed HIV Infection - United States, 2008–20122015
- Two years of Truvada for pre‐exposure prophylaxis utilization in the USJournal of the International AIDS Society, 2014
- A Method for Educating Patients and Documenting Smoking Status in an Electronic Medical RecordAnnals of Pharmacotherapy, 2009